Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Influences of Salinity and Organic Compounds on Embryo Development in Three Medaka Oryzias Congeners with Habitats Ranging from Freshwater to Marine.

Horie Y, Kanazawa N, Suzuki A, Yonekura K, Chiba T.

Bull Environ Contam Toxicol. 2019 Jun 15. doi: 10.1007/s00128-019-02649-3. [Epub ahead of print]

PMID:
31203410
2.

Molecular mechanism of the flexible glycan-receptor recognition by mumps virus.

Kubota M, Matsuoka R, Suzuki T, Yonekura K, Yanagi Y, Hashiguchi T.

J Virol. 2019 May 22. pii: JVI.00344-19. doi: 10.1128/JVI.00344-19. [Epub ahead of print]

PMID:
31118251
3.

Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).

Hamada T, Tokura Y, Sugaya M, Ohtsuka M, Tsuboi R, Nagatani T, Kiyohara E, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Saida T, Iwatsuki K.

J Dermatol. 2019 May 15. doi: 10.1111/1346-8138.14923. [Epub ahead of print]

PMID:
31090237
4.

Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma.

Yonekura K, Takeda K, Kawakami N, Kanzaki T, Kanekura T, Utsunomiya A.

Acta Derm Venereol. 2019 Apr 16. doi: 10.2340/00015555-3196. [Epub ahead of print]

5.

A new cryo-EM system for single particle analysis.

Hamaguchi T, Maki-Yonekura S, Naitow H, Matsuura Y, Ishikawa T, Yonekura K.

J Struct Biol. 2019 Jul 1;207(1):40-48. doi: 10.1016/j.jsb.2019.04.011. Epub 2019 Apr 13.

6.

A new cryo-EM system for electron 3D crystallography by eEFD.

Yonekura K, Ishikawa T, Maki-Yonekura S.

J Struct Biol. 2019 May 1;206(2):243-253. doi: 10.1016/j.jsb.2019.03.009. Epub 2019 Mar 27.

7.

[A Case Report of Recurrent Bleeding and Massive Malodorous Effusion Due to Skin Invasion of Advanced Breast Cancer Successfully Treated with Mohs' Paste].

Satoh E, Osanai T, Tomi Y, Nakamura M, Yonekura K, Murakata A, Motoyama K, Tanami H, Sugano N, Sakoma T.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1997-1999. Japanese.

PMID:
30692423
8.

Prognostic impact of soluble interleukin-2 receptor level profiling in smoldering type adult T-cell leukemia-lymphoma.

Kubota A, Nakano N, Tokunaga M, Miyazono T, Tokunaga M, Makino T, Takeuchi S, Yonekura K, Takatsuka Y, Utsunomiya A.

Hematol Oncol. 2019 Apr;37(2):223-225. doi: 10.1002/hon.2574. Epub 2019 Feb 6. No abstract available.

PMID:
30656718
9.

Cross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitors.

Tsuruta N, Narisawa Y, Imafuku S, Ito K, Yamaguchi K, Miyagi T, Takahashi K, Fukamatsu H, Morizane S, Koketsu H, Yamaguchi M, Hino R, Nakamura M, Ohyama B, Ohata C, Kuwashiro M, Sato T, Saito K, Kaneko S, Yonekura K, Hayashi H, Yanase T, Morimoto K, Sugita K, Yanagihara S, Kikuchi S, Mitoma C, Nakahara T, Furue M, Okazaki F.

J Dermatol. 2019 Mar;46(3):193-198. doi: 10.1111/1346-8138.14745. Epub 2019 Jan 10.

PMID:
30628100
10.

Ecotoxicological Test Assay Using OECD TG 212 in Marine Java Medaka (Oryzias javanicus) and Freshwater Japanese Medaka (Oryzias latipes).

Horie Y, Kanazawa N, Yamagishi T, Yonekura K, Tatarazako N.

Bull Environ Contam Toxicol. 2018 Sep;101(3):344-348. doi: 10.1007/s00128-018-2398-1. Epub 2018 Jul 18.

PMID:
30022344
11.

Sézary syndrome in an anti-human T-cell lymphotropic virus type 1 seropositive carrier.

Baba N, Fujii K, Nomoto Y, Jimura N, Higashi Y, Takami S, Masamoto I, Yonekura K, Mera K, Kanekura T.

J Dermatol. 2019 Jan;46(1):e40-e41. doi: 10.1111/1346-8138.14522. Epub 2018 Jun 28. No abstract available.

PMID:
29952024
12.

CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Sakamoto Y, Ishida T, Masaki A, Murase T, Yonekura K, Tashiro Y, Tokunaga M, Utsunomiya A, Ito A, Kusumoto S, Iida S, Ueda R, Inagaki H.

Blood. 2018 Aug 16;132(7):758-761. doi: 10.1182/blood-2018-02-835991. Epub 2018 Jun 21. No abstract available.

PMID:
29930010
13.

Hopkins syndrome following the first episode of bronchial asthma associated with enterovirus D68: a case report.

Hayashi F, Hayashi S, Matsuse D, Yamasaki R, Yonekura K, Kira JI.

BMC Neurol. 2018 May 23;18(1):71. doi: 10.1186/s12883-018-1075-7.

14.

Ionic scattering factors of atoms that compose biological molecules.

Yonekura K, Matsuoka R, Yamashita Y, Yamane T, Ikeguchi M, Kidera A, Maki-Yonekura S.

IUCrJ. 2018 Apr 27;5(Pt 3):348-353. doi: 10.1107/S2052252518005237. eCollection 2018 May 1.

15.

TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations.

Hasako S, Terasaka M, Abe N, Uno T, Ohsawa H, Hashimoto A, Fujita R, Tanaka K, Okayama T, Wadhwa R, Miyadera K, Aoyagi Y, Yonekura K, Matsuo K.

Mol Cancer Ther. 2018 Aug;17(8):1648-1658. doi: 10.1158/1535-7163.MCT-17-1206. Epub 2018 May 10.

PMID:
29748209
16.

Correction: Hexameric and pentameric complexes of the ExbBD energizer in the Ton system.

Yonekura K, Maki-Yonekura S, Matsuoka R, Yamashita Y, Shimizu H, Tanaka M, Iwabuki F.

Elife. 2018 May 4;7. pii: e37833. doi: 10.7554/eLife.37833. No abstract available.

17.

Hexameric and pentameric complexes of the ExbBD energizer in the Ton system.

Maki-Yonekura S, Matsuoka R, Yamashita Y, Shimizu H, Tanaka M, Iwabuki F, Yonekura K.

Elife. 2018 Apr 17;7. pii: e35419. doi: 10.7554/eLife.35419. Erratum in: Elife. 2018 May 04;7:.

18.

Indium-Catalyzed Annulation of o-Acylanilines with Alkoxyheteroarenes: Synthesis of Heteroaryl[b]quinolines and Subsequent Transformation to Cryptolepine Derivatives.

Yonekura K, Shinoda M, Yonekura Y, Tsuchimoto T.

Molecules. 2018 Apr 5;23(4). pii: E838. doi: 10.3390/molecules23040838.

19.

[A Case of Non-Functioning Pancreatic Neuroendocrine Tumor Accompanied by Stenosis of the Main Pancreatic Duct].

Ishii T, Nakamura N, Saitou T, Yonekura K, Watanabe Y, Sanada T, Kuwabara H, Goseki N, Koike M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1632-1634. Review. Japanese.

PMID:
29394725
20.

[A Case of Extrarenal Retroperitoneal Angiomyolipoma].

Saito T, Watanabe Y, Ishii T, Yonekura K, Sanada T, Kuwabara H, Nakamura N, Goseki N.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1346-1348. Review. Japanese.

PMID:
29394629
21.

Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.

Obata Y, Horikawa K, Shiina I, Takahashi T, Murata T, Tasaki Y, Suzuki K, Yonekura K, Esumi H, Nishida T, Abe R.

Cancer Lett. 2018 Feb 28;415:1-10. doi: 10.1016/j.canlet.2017.11.032. Epub 2017 Nov 28.

22.

Fukushima Triple Disaster and the Road to Recovery: a Qualitative Exploration of Resilience in Internally Displaced Residents.

Mann CL, Gillezeau CN, Massazza A, Lyons DJ, Tanaka K, Yonekura K, Sekine H, Yanagisawa R, Katz CL.

Psychiatr Q. 2018 Jun;89(2):383-397. doi: 10.1007/s11126-017-9542-7.

PMID:
29079958
23.

Derivation of the Time-Reversal Anomaly for (2+1)-Dimensional Topological Phases.

Tachikawa Y, Yonekura K.

Phys Rev Lett. 2017 Sep 15;119(11):111603. doi: 10.1103/PhysRevLett.119.111603. Epub 2017 Sep 13.

PMID:
28949209
24.

Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.

Tokunaga M, Yonekura K, Nakamura D, Haraguchi K, Tabuchi T, Fujino S, Hayashida M, Maekawa K, Arai A, Nakano N, Kamada Y, Kubota A, Inoue H, Owatari S, Takeuchi S, Takatsuka Y, Otsuka M, Hanada S, Matsumoto T, Yoshimitsu M, Ishitsuka K, Utsunomiya A.

Br J Haematol. 2018 May;181(4):539-542. doi: 10.1111/bjh.14634. Epub 2017 Apr 3. No abstract available.

PMID:
28369823
25.

[Resection of Pancreatic Metastasis from Renal Cell Carcinoma 21 Years after Nephrectomy].

Miura T, Nakamura N, Ogawa K, Watanabe Y, Yonekura K, Sanada T, Kuwabara H, Goseki N.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2187-2189. Review. Japanese.

PMID:
28133264
26.

Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sections.

Kato J, Masaki A, Fujii K, Takino H, Murase T, Yonekura K, Utsunomiya A, Ishida T, Iida S, Inagaki H.

Pathol Int. 2016 Nov;66(11):618-621. doi: 10.1111/pin.12462. Epub 2016 Sep 27.

PMID:
27678343
27.

High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.

Fujita H, Gomori A, Fujioka Y, Kataoka Y, Tanaka K, Hashimoto A, Suzuki T, Ito K, Haruma T, Yamamoto-Yokoi H, Harada N, Sakuragi M, Oda N, Matsuo K, Inada M, Yonekura K.

PLoS One. 2016 Oct 13;11(10):e0164830. doi: 10.1371/journal.pone.0164830. eCollection 2016.

28.

Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.

Hamada T, Sugaya M, Tokura Y, Ohtsuka M, Tsuboi R, Nagatani T, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Yoshida T, Saida T, Iwatsuki K.

J Dermatol. 2017 Feb;44(2):135-142. doi: 10.1111/1346-8138.13542. Epub 2016 Aug 20.

PMID:
27543197
29.

The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.

Watanabe K, Hirata M, Tominari T, Matsumoto C, Fujita H, Yonekura K, Murphy G, Nagase H, Miyaura C, Inada M.

J Biol Chem. 2016 Sep 30;291(40):20891-20899. Epub 2016 Aug 18.

30.

Search for a Minimal N=1 Superconformal Field Theory in 4D.

Xie D, Yonekura K.

Phys Rev Lett. 2016 Jul 1;117(1):011604. doi: 10.1103/PhysRevLett.117.011604. Epub 2016 Jul 1.

PMID:
27419561
31.

Taste substance binding elicits conformational change of taste receptor T1r heterodimer extracellular domains.

Nango E, Akiyama S, Maki-Yonekura S, Ashikawa Y, Kusakabe Y, Krayukhina E, Maruno T, Uchiyama S, Nuemket N, Yonekura K, Shimizu M, Atsumi N, Yasui N, Hikima T, Yamamoto M, Kobayashi Y, Yamashita A.

Sci Rep. 2016 May 10;6:25745. doi: 10.1038/srep25745.

32.

Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma.

Yonekura K, Tokunaga M, Kawakami N, Takeda K, Kanzaki T, Nakano N, Kubota A, Takeuchi S, Takatsuka Y, Seto M, Utsunomiya A.

Acta Derm Venereol. 2016 Nov 2;96(7):1000-1002. doi: 10.2340/00015555-2421. No abstract available.

33.

Cryogenic coherent X-ray diffraction imaging of biological samples at SACLA: a correlative approach with cryo-electron and light microscopy.

Takayama Y, Yonekura K.

Acta Crystallogr A Found Adv. 2016 Mar;72(Pt 2):179-89. doi: 10.1107/S2053273315023980. Epub 2016 Jan 29.

PMID:
26919369
34.

Cosmologically Safe QCD Axion without Fine-Tuning.

Yamada M, Yanagida TT, Yonekura K.

Phys Rev Lett. 2016 Feb 5;116(5):051801. doi: 10.1103/PhysRevLett.116.051801. Epub 2016 Feb 5.

PMID:
26894701
35.

[A Case of Brain Metastases from Pancreatic Cancer That Had Been Treated Effectively with FOLFIRINOX].

Miura T, Nakamura N, Kurihara Y, Yonekura K, Watanabe Y, Sanada T, Kuwabara H, Goseki N.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2357-9. Review. Japanese.

PMID:
26805363
36.

Darier's Disease with Esophageal Involvement.

Baba A, Yonekura K, Takeda K, Kawai K, Kanekura T.

Acta Dermatovenerol Croat. 2015;23(3):218-9. No abstract available.

PMID:
26476908
37.

A Comparative Study Between Deep Inferior Epigastric Artery Perforator and Thoracoacromial Venous Supercharged Deep Inferior Epigastric Artery Perforator Flaps.

Ayestaray B, Yonekura K, Motomura H, Ziade M.

Ann Plast Surg. 2016 Jan;76(1):78-82. doi: 10.1097/SAP.0000000000000581.

PMID:
26207537
38.

Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.

Yonekura K, Utsunomiya A, Seto M, Takatsuka Y, Takeuchi S, Tokunaga M, Kubota A, Takeda K, Kanzaki T, Uchida Y, Kawai K, Kanekura T.

J Dermatol. 2015 Dec;42(12):1143-8. doi: 10.1111/1346-8138.13004. Epub 2015 Jun 30.

PMID:
26134467
39.

[A case of cardiac tamponade due to pericarditis carcinomatosa of breast cancer successfully treated via pericardiocentesis and systemic chemo-endocrine therapy].

Satoh E, Ebuchi M, Suzuki K, Uehira D, Ono S, Yonekura K, Murakata A, Tanami H, Maruyama S, Sugano N, Maruyama M, Matsumoto J, Sakoma T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1895-6. Japanese.

PMID:
25731367
40.

Electron crystallography of ultrathin 3D protein crystals: atomic model with charges.

Yonekura K, Kato K, Ogasawara M, Tomita M, Toyoshima C.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3368-73. doi: 10.1073/pnas.1500724112. Epub 2015 Feb 17.

41.

Signal enhancement and Patterson-search phasing for high-spatial-resolution coherent X-ray diffraction imaging of biological objects.

Takayama Y, Maki-Yonekura S, Oroguchi T, Nakasako M, Yonekura K.

Sci Rep. 2015 Jan 28;5:8074. doi: 10.1038/srep08074.

42.

TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models.

Ohkubo S, Kodama Y, Muraoka H, Hitotsumachi H, Yoshimura C, Kitade M, Hashimoto A, Ito K, Gomori A, Takahashi K, Shibata Y, Kanoh A, Yonekura K.

Mol Cancer Ther. 2015 Jan;14(1):14-22. doi: 10.1158/1535-7163.MCT-14-0219. Epub 2014 Nov 21.

43.

Changes in dermal papilla structures due to aging in the facial cheek region.

Mizukoshi K, Yonekura K, Futagawa M, Nakamura T, Hirayama K, Takahashi K.

Skin Res Technol. 2015 May;21(2):224-31. doi: 10.1111/srt.12180. Epub 2014 Aug 23.

PMID:
25156803
44.

Crisis of Japanese vascular flora shown by quantifying extinction risks for 1618 taxa.

Kadoya T, Takenaka A, Ishihama F, Fujita T, Ogawa M, Katsuyama T, Kadono Y, Kawakubo N, Serizawa S, Takahashi H, Takamiya M, Fujii S, Matsuda H, Muneda K, Yokota M, Yonekura K, Yahara T.

PLoS One. 2014 Jun 12;9(6):e98954. doi: 10.1371/journal.pone.0098954. eCollection 2014.

45.

Single-shot three-dimensional structure determination of nanocrystals with femtosecond X-ray free-electron laser pulses.

Xu R, Jiang H, Song C, Rodriguez JA, Huang Z, Chen CC, Nam D, Park J, Gallagher-Jones M, Kim S, Kim S, Suzuki A, Takayama Y, Oroguchi T, Takahashi Y, Fan J, Zou Y, Hatsui T, Inubushi Y, Kameshima T, Yonekura K, Tono K, Togashi T, Sato T, Yamamoto M, Nakasako M, Yabashi M, Ishikawa T, Miao J.

Nat Commun. 2014 Jun 5;5:4061. doi: 10.1038/ncomms5061.

PMID:
24898682
46.

Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.

Nakade J, Takeuchi S, Nakagawa T, Ishikawa D, Sano T, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, Matsumoto K, Yonekura K, Yano S.

J Thorac Oncol. 2014 Jun;9(6):775-83. doi: 10.1097/JTO.0000000000000170.

47.

Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.

Yonekura K, Kanzaki T, Gunshin K, Kawakami N, Takatsuka Y, Nakano N, Tokunaga M, Kubota A, Takeuchi S, Kanekura T, Utsunomiya A.

J Dermatol. 2014 Mar;41(3):239-44. doi: 10.1111/1346-8138.12419.

PMID:
24628073
48.

Post-transcriptional regulator Hfq binds catalase HPII: crystal structure of the complex.

Yonekura K, Watanabe M, Kageyama Y, Hirata K, Yamamoto M, Maki-Yonekura S.

PLoS One. 2013 Nov 6;8(11):e78216. doi: 10.1371/journal.pone.0078216. eCollection 2013.

49.

The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.

Fujita H, Miyadera K, Kato M, Fujioka Y, Ochiiwa H, Huang J, Ito K, Aoyagi Y, Takenaka T, Suzuki T, Ito S, Hashimoto A, Suefuji T, Egami K, Kazuno H, Suda Y, Nishio K, Yonekura K.

Mol Cancer Ther. 2013 Dec;12(12):2685-96. doi: 10.1158/1535-7163.MCT-13-0459. Epub 2013 Oct 18.

50.

Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.

Staals RHJ, Agari Y, Maki-Yonekura S, Zhu Y, Taylor DW, van Duijn E, Barendregt A, Vlot M, Koehorst JJ, Sakamoto K, Masuda A, Dohmae N, Schaap PJ, Doudna JA, Heck AJR, Yonekura K, van der Oost J, Shinkai A.

Mol Cell. 2013 Oct 10;52(1):135-145. doi: 10.1016/j.molcel.2013.09.013.

Supplemental Content

Loading ...
Support Center